RhumbLine Advisers’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.1M | Buy |
262,683
+6,748
| +3% | +$648K | 0.02% | 652 |
|
|
2026
Q1 | $26.5M | Sell |
255,935
-6,571
| -3% | -$745K | 0.02% | 589 |
|
|
2025
Q4 | $26.5M | Buy |
262,506
+2,320
| +0.9% | +$252K | 0.02% | 592 |
|
|
2025
Q3 | $32.1M | Sell |
260,186
-219
| -0.1% | -$27.2K | 0.03% | 529 |
|
|
2025
Q2 | $31.3M | Sell |
260,405
-13,057
| -5% | -$1.74M | 0.03% | 526 |
|
|
2025
Q1 | $40.3M | Buy |
273,462
+14,647
| +6% | +$2.24M | 0.04% | 409 |
|
|
2024
Q4 | $42M | Sell |
258,815
-11,272
| -4% | -$1.84M | 0.04% | 394 |
|
|
2024
Q3 | $44M | Sell |
270,087
-7,234
| -3% | -$1.07M | 0.04% | 379 |
|
|
2024
Q2 | $37.8M | Buy |
277,321
+3,992
| +1% | +$554K | 0.04% | 402 |
|
|
2024
Q1 | $41.8M | Buy |
273,329
+2,385
| +0.9% | +$356K | 0.04% | 375 |
|
|
2023
Q4 | $38.6M | Buy |
270,944
+933
| +0.3% | +$124K | 0.04% | 385 |
|
|
2023
Q3 | $35.4M | Buy |
270,011
+994
| +0.4% | +$151K | 0.04% | 382 |
|
|
2023
Q2 | $42.8M | Buy |
269,017
+12,440
| +5% | +$2.01M | 0.05% | 343 |
|
|
2023
Q1 | $40.6M | Buy |
256,577
+14,011
| +6% | +$2.1M | 0.05% | 333 |
|
|
2022
Q4 | $34M | Buy |
242,566
+9,244
| +4% | +$1.31M | 0.05% | 375 |
|
|
2022
Q3 | $30M | Buy |
233,322
+4,877
| +2% | +$704K | 0.04% | 378 |
|
|
2022
Q2 | $32.2M | Buy |
228,445
+13,209
| +6% | +$1.89M | 0.05% | 351 |
|
|
2022
Q1 | $29.9M | Sell |
215,236
-7,437
| -3% | -$1.14M | 0.04% | 408 |
|
|
2021
Q4 | $38.8M | Sell |
222,673
-9,088
| -4% | -$1.51M | 0.05% | 340 |
|
|
2021
Q3 | $38.4M | Sell |
231,761
-3,864
| -2% | -$665K | 0.05% | 324 |
|
|
2021
Q2 | $42.4M | Sell |
235,625
-4,782
| -2% | -$873K | 0.06% | 300 |
|
|
2021
Q1 | $46.4M | Sell |
240,407
-26,685
| -10% | -$5.14M | 0.06% | 266 |
|
|
2020
Q4 | $53.9M | Sell |
267,092
-32,488
| -11% | -$6.72M | 0.07% | 233 |
|
|
2020
Q3 | $63M | Buy |
299,580
+11,104
| +4% | +$2.47M | 0.1% | 177 |
|
|
2020
Q2 | $63.3M | Buy |
288,476
+26,816
| +10% | +$5.36M | 0.11% | 166 |
|
|
2020
Q1 | $45.3M | Buy |
261,660
+3,065
| +1% | +$506K | 0.1% | 187 |
|
|
2019
Q4 | $39.7M | Buy |
258,595
+4,193
| +2% | +$627K | 0.07% | 273 |
|
|
2019
Q3 | $38.6M | Buy |
254,402
+1,289
| +0.5% | +$204K | 0.07% | 254 |
|
|
2019
Q2 | $38.8M | Sell |
253,113
-10,582
| -4% | -$1.62M | 0.07% | 252 |
|
|
2019
Q1 | $42.3M | Sell |
263,695
-6,833
| -3% | -$1.06M | 0.08% | 216 |
|
|
2018
Q4 | $41.7M | Sell |
270,528
-5,954
| -2% | -$928K | 0.09% | 205 |
|
|
2018
Q3 | $41.6M | Sell |
276,482
-13,203
| -5% | -$1.88M | 0.08% | 242 |
|
|
2018
Q2 | $39.2M | Buy |
289,685
+1,323
| +0.5% | +$163K | 0.08% | 244 |
|
|
2018
Q1 | $38.4M | Sell |
288,362
-11,820
| -4% | -$1.59M | 0.08% | 251 |
|
|
2017
Q4 | $44.6M | Sell |
300,182
-3,683
| -1% | -$501K | 0.09% | 226 |
|
|
2017
Q3 | $40.1M | Buy |
303,865
+2,730
| +0.9% | +$367K | 0.09% | 238 |
|
|
2017
Q2 | $40.1M | Buy |
301,135
+2,171
| +0.7% | +$293K | 0.09% | 234 |
|
|
2017
Q1 | $40.3M | Buy |
298,964
+11,571
| +4% | +$1.5M | 0.09% | 224 |
|
|
2016
Q4 | $34.5M | Buy |
287,393
+57,350
| +25% | +$6.76M | 0.09% | 241 |
|
|
2016
Q3 | $28.8M | Sell |
230,043
-5,778
| -2% | -$757K | 0.08% | 252 |
|
|
2016
Q2 | $32.6M | Buy |
235,821
+12,991
| +6% | +$1.68M | 0.1% | 220 |
|
|
2016
Q1 | $28.1M | Buy |
222,830
+14,333
| +7% | +$1.82M | 0.09% | 235 |
|
|
2015
Q4 | $26.4M | Buy |
208,497
+4,839
| +2% | +$601K | 0.09% | 230 |
|
|
2015
Q3 | $23.5M | Buy |
203,658
+4,417
| +2% | +$496K | 0.08% | 253 |
|
|
2015
Q2 | $20.7M | Buy |
199,241
+20,704
| +12% | +$2.23M | 0.07% | 293 |
|
|
2015
Q1 | $19.7M | Buy |
178,537
+454
| +0.3% | +$49.3K | 0.06% | 299 |
|
|
2014
Q4 | $18.6M | Buy |
178,083
+215
| +0.1% | +$21.5K | 0.05% | 316 |
|
|
2014
Q3 | $17.1M | Sell |
177,868
-3,062
| -2% | -$277K | 0.05% | 324 |
|
|
2014
Q2 | $16.5M | Sell |
180,930
-14,312
| -7% | -$1.28M | 0.05% | 343 |
|
|
2014
Q1 | $17.2M | Sell |
195,242
-8,984
| -4% | -$789K | 0.05% | 335 |
|
|
2013
Q4 | $18.9M | Sell |
204,226
-11,215
| -5% | -$1.01M | 0.06% | 311 |
|
|
2013
Q3 | $17.6M | Buy |
215,441
+3,663
| +2% | +$309K | 0.05% | 328 |
|
|
2013
Q2 | $17.6M | Buy |
+211,778
| New | +$18.2M | 0.06% | 315 |
|
Other funds holding CLX
RhumbLine Advisers's CLX Position: Q2 2026 in Review
RhumbLine Advisers increased its Clorox (CLX) stake by 2.6% in Q2 2026, buying an estimated $648K and bringing the position to 262,683 shares worth $25.1M. The position accounts for 0.02% of the portfolio, ranked #652.
RhumbLine Advisers first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $63.3M in Q2 2020. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- RhumbLine Advisers held 262,683 shares of Clorox worth $25.1M as of Q2 2026.
- RhumbLine Advisers bought 6,748 Clorox shares in Q2 2026, an estimated $648K.
- Clorox made up 0.02% of RhumbLine Advisers's portfolio in Q2 2026, its #652 holding.
- RhumbLine Advisers first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Clorox position peaked at $63.3M in Q2 2020.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.